J-113863

J-113863 is an antagonist of CCR used in studies of NF-kB Signaling and Immune Signaling and related signaling programs. It is especially relevant in immunology and inflammation models, where defined compound exposure can be linked to inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses.

By blocking CCR, J-113863 can be used to examine inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In immunology and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving CCR
• Pathway perturbation studies connected to NF-kB Signaling and Immune Signaling and related signaling programs
• Receptor-blockade and ligand-competition studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, J-113863 is appropriate when a defined chemical perturbant is needed to connect CCR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in immunology and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.